Mosaiq Aiplex Vasculitis Assay Now CE Mark Approved
August 4, 2025
AliveDx achieves IVDR-CE Mark for a multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to advance the testing of Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides and Anti-GBM (Goodpasture’s) disease